Is Tandem Diabetes Care Stock a Buy?
Is the optimism surrounding this insulin pump maker justified?
Tandem Diabetes Care
TNDM
TNDM
$61.22
-$0.66
-1.1%
BATS BZX Real Time Price as of December 6, 2019, 4:00 p.m. EST
View Interactive TNDM Charts
Tandem Diabetes Care, Inc.
News & Analysis: Tandem Diabetes Care
3 Fast-Growing Medtech Stocks to Buy
Including one or more of these three top medical-device companies in your portfolio now could be savvy.
3 Top Diabetes Stocks to Watch in November
There are some highly promising diabetes treatments entering the market that investors should know about.
How Tandem Diabetes Care Blew Past Wall Street Estimates in Q3
The insulin pump maker once again delivered stellar quarterly results.
Tandem Diabetes Care Inc (TNDM) Q3 2019 Earnings Call Transcript
TNDM earnings call for the period ending September 30, 2019.
Here's Why Tandem Diabetes Care Fell 18.6% in September
The growth stock cooled off a bit last month but has still managed to scorch the market with a 51% year-to-date gain.
2 Growth Stocks for In-the-Know Investors
These two healthcare businesses are capturing formidable growth opportunities by executing in their overlooked niches.
Here's Why Tandem Diabetes Care Jumped 14.2% in August
The medical device company is cruising past everyone's expectations -- including its own.
3 Top Growth Stocks to Buy in the Final Month of Summer
The dog days of summer are finally behind us (on the calendar, anyway), but these three stocks offer sizzling growth potential.
3 Top Diabetes Stocks to Watch in August
These three diabetes-oriented companies should be on your radar right now.
